Alterity Therapeutics Limited (ATHE)

NASDAQ: ATHE · Real-Time Price · USD

4.210

+0.100 (2.43%)

At close: Sep 11, 2026, 4:00 PM EDT

4.050

-0.160 (-3.80%)

After-hours: Sep 11, 2026, 7:30 PM EDT

Alterity Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Equivalents	37.32	33.16	12.64	15.77	34.81
Short-Term Investments	-	7.5	-	-	-
Cash & Short-Term Investments	37.32	40.66	12.64	15.77	34.81
Cash Growth	-8.22%	221.70%	-19.87%	-54.68%	23.80%
Accounts Receivable	7.54	3.93	4.02	8.65	4.67
Other Receivables	0.16	0.01	0.02	0.02	0.06
Receivables	7.7	3.94	4.04	8.67	4.73
Prepaid Expenses	0.77	1.23	2.32	2.57	1.6
Other Current Assets	0.04	0.04	0.04	0.04	0.01
Total Current Assets	45.83	45.87	19.04	27.05	41.14
Property, Plant & Equipment	0.19	0.16	0.19	0.27	0.22
Total Assets	46.02	46.03	19.22	27.32	41.36

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Accounts Payable	1.12	0.54	0.58	1.72	2.66
Accrued Expenses	1.92	2.89	4.56	2.5	3.02
Current Portion of Leases	0.06	0.07	0.11	0.11	0.06
Current Income Taxes Payable	0.05	0.02	0.02	0.03	0.03
Other Current Liabilities	0.02	0.02	0.11	0.03	0.06
Total Current Liabilities	3.16	3.53	5.37	4.38	5.82
Long-Term Leases	0.14	0.09	0.05	0.1	0.06
Other Long-Term Liabilities	-	-0	-	0.02	0.01
Total Liabilities	3.29	3.62	5.43	4.5	5.89

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Common Stock	282.51	262.95	223.15	213.97	213.79
Retained Earnings	-245.58	-225.89	-214.16	-195.13	-181.88
Comprehensive Income & Other	5.8	5.34	4.81	3.97	3.57
Shareholders' Equity	42.72	42.4	13.8	22.81	35.47
Total Liabilities & Equity	46.02	46.03	19.22	27.32	41.36

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Total Debt	0.19	0.16	0.16	0.21	0.12
Net Cash (Debt)	37.12	40.5	12.48	15.56	34.69
Net Cash Growth	-8.34%	224.55%	-19.81%	-55.13%	23.67%
Net Cash Per Share	0.18	0.32	0.17	0.32	0.72
Filing Date Shares Outstanding	218.5	184.17	106.41	48.8	48.14
Total Common Shares Outstanding	217.51	182.55	104.9	48.8	48.14
Working Capital	42.67	42.34	13.66	22.67	35.32
Book Value Per Share	0.20	0.23	0.13	0.47	0.74
Tangible Book Value	42.72	42.4	13.8	22.81	35.47
Tangible Book Value Per Share	0.20	0.23	0.13	0.47	0.74

SEC Filings: 10-K · 10-Q